S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical Cancer Research

• Publication date

  2012-06-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-12-0221PMID 22718861PMCID PMC3845828
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• S100P: a novel therapeutic target for cancer

  2011cited by this paper
• HMGB1 and RAGE in inflammation and cancer.

  2010cited by this paper
• S100A4 and metastasis: a small actor playing many roles.

  2010cited by this paper
• S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer.

  2007cited by this paper
• RAGE and RAGE ligands in cancer.

  2007influential reference
• Pathologies involving the S100 proteins and RAGE.

  2007influential reference
• Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models.

  2006influential reference
• High mobility group box 1 protein interacts with multiple Toll-like receptors.

  2006cited by this paper
• RAGE in inflammation: a new therapeutic target?

  2006cited by this paper
• Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.

  2005cited by this paper
• Understanding RAGE, the receptor for advanced glycation end products

  2005cited by this paper
• S100P Promotes Pancreatic Cancer Growth, Survival, and Invasion

  2005cited by this paper
• Timing of Percutaneous Endoscopic Gastrostomy Tube Placement After Cervical Esophageal Reconstruction With Free Jejunal Transfer

  2004cited by this paper
• S100P Stimulates Cell Proliferation and Survival via Receptor for Activated Glycation End Products (RAGE)*

  2004cited by this paper
• Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions.

  2004cited by this paper
• Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.

  2004cited by this paper
• RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

  2003cited by this paper
• The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins

  2003cited by this paper
• Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis.

  2002influential reference
• NF-κB in cancer: from innocent bystander to major culprit

  2002cited by this paper
• Pattern recognition receptors: doubling up for the innate immune response.

  2002cited by this paper
• RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice

  2002cited by this paper
• Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

  2002cited by this paper
• NF-kappaB in cancer: from innocent bystander to major culprit.

  2002cited by this paper
• Expression of receptors for advanced glycation end‐products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer

  2002cited by this paper
• Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

  2001cited by this paper
• The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.

  2001cited by this paper
• The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells

  1999cited by this paper
• The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.

  1999cited by this paper
• Blockade of RAGE ± amphoterin signalling suppresses tumour growth and metastases

  year unknowncited by this paper

• Oxycodone induces HMGB1-mediated neuroimmune crosstalk between oligodendrocytes and microglia.

  2026cites this paper
• Exogenous prostaglandin D2 as a modulator in bovine endometritis: implications for reducing antibiotic use in dairy cattle

  2025cites this paper
• Soluble form of tumor necrosis factor-related apoptosis-inducing ligand interacts with S100P protein.

  2025cites this paper
• Integrative multi-omics identifies S100A8/IGFBP5/CTSK/S100P as dual diagnostic biomarkers and therapeutic targets in Crohn's disease: from computational discovery to preclinical validation.

  2025cites this paper
• S100A4/FSP1: A Prognostic Marker and a Promising Target for Antitumor Therapy

  2025cites this paper
• Targeting myeloid cells to improve cancer immune therapy

  2025cites this paper
• Ability of magnesium implants to remodel the osteoporotic immune microenvironment in a murine femoral fracture model

  2025cites this paper
• S100 Protein Family in Lung Cancer: an Updated Narrative Review

  2025cites this paper
• Endosome-phagophore linking assemblies for the degradation of membrane/extracellular proteins

  2025cites this paper
• The long noncoding RNA LUCAT1 regulates endometrial receptivity via the miR-495-3p/S100P axis

  2025cites this paper
• Clinical and mechanistic insights into the expression of SP100 family proteins in various cancers: a systematic review

  2025cites this paper
• S100P binds to RAGE and activates ERK/NF-κB signaling to promote osteoclast differentiation and activity.

  2024cites this paper
• The RAGE Inhibitor TTP488 (Azeliragon) Demonstrates Anti-Tumor Activity and Enhances the Efficacy of Radiation Therapy in Pancreatic Cancer Cell Lines

  2024cites this paper
• Pathological role of RAGE underlying progression of various diseases: its potential as biomarker and therapeutic target

  2024cites this paper
• AGEs impair osteogenesis in orthodontic force-induced periodontal ligament stem cells through the KDM6B/Wnt self-reinforcing loop

  2024cites this paper
• Human iPSC-based disease modeling studies identify a common mechanistic defect and potential therapies for AMD and related macular dystrophies.

  2024cites this paper
• Unveiling Novel Drug Targets and Emerging Therapies for Rheumatoid Arthritis: A Comprehensive Review

  2024cites this paper
• A patent review on HMGB1 inhibitors for the treatment of liver diseases

  2024cites this paper
• Nε-(1-Carboxymethyl)-L-lysine/RAGE Signaling Drives Metastasis and Cancer Stemness through ERK/NFκB axis in Osteosarcoma

  2024cites this paper
• Cyclophilin A is a ligand for RAGE in thrombo-inflammation.

  2024cites this paper
• Pharmacological Targeting of the RAGE-NFκB Signalling Axis Impedes Monocyte Activation under Diabetic Conditions through the Repression of SHP-2 Tyrosine Phosphatase Function

  2023cites this paper
• Receptor for advanced glycation end-products: Biological significance and imaging applications.

  2023cites this paper
• S100P as a potential biomarker for immunosuppressive microenvironment in pancreatic cancer: a bioinformatics analysis and in vitro study

  2023cites this paper
• S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors

  2023cites this paper
• AGEs promote atherosclerosis by increasing LDL transcytosis across endothelial cells via RAGE/NF-κB/Caveolin-1 pathway

  2023cites this paper
• RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer

  2023cites this paper
• Targeted Destruction of S100A4 Inhibits Metastasis of Triple Negative Breast Cancer Cells

  2023cites this paper
• RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer

  2023cites this paper
• Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease

  2023cites this paper
• Roles and Molecular Mechanisms of Biomarkers in Hepatocellular Carcinoma with Microvascular Invasion: A Review

  2023cites this paper
• Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy

  2023cites this paper
• esRAGE-expressing oHSV enhances anti-tumor efficacy by inhibition of endothelial cell activation

  2023cites this paper
• Inhibition of HMGB1/RAGE Signaling Reduces the Incidence of Medication‐Related Osteonecrosis of the Jaw (MRONJ) in Mice

  2022cites this paper
• RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review

  2022cites this paper
• Differential gene expression analysis of RAGE‐S100A6 complex for target selection and the design of novel inhibitors for anticancer drug discovery

  2022cites this paper
• Receptor of advanced glycation end-products axis and gallbladder cancer: A forgotten connection that we should reconsider

  2022cites this paper
• Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease

  2022cites this paper
• Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases

  2022cites this paper
• Role and therapeutic potential of RAGE signaling in neurodegeneration.

  2022cites this paper
• Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC)

  2022cites this paper
• The RAGE/DIAPH1 Signaling Axis & Implications for the Pathogenesis of Diabetic Complications

  2022cites this paper
• A Structural Perspective on Calprotectin as a Ligand of Receptors Mediating Inflammation and Potential Drug Target

  2022cites this paper
• 4-Acetylantroquinonol B enhances cell death and inhibits autophagy by downregulating the PI3K/Akt/MDR1 pathway in gemcitabine-resistant pancreatic cancer cells

  2022cites this paper
• Dual Nature of RAGE in Host Reaction and Nurturing the Mother–Infant Bond

  2022cites this paper
• Intelligent lesion blood–brain barrier targeting nano-missiles for Alzheimer's disease treatment by anti-neuroinflammation and neuroprotection

  2022cites this paper
• Consequences of COVID-19 for the Pancreas

  2022cites this paper
• Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy

  2021cites this paper
• S100 Proteins in Pancreatic Cancer: Current Knowledge and Future Perspectives

  2021cites this paper
• A fragment‐based approach to discovery of Receptor for Advanced Glycation End products inhibitors

  2021cites this paper
• Identification of pheophorbide a as an inhibitor of receptor for advanced glycation end products in Mallotus japonicus

  2021cites this paper
• Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives

  2021cites this paper
• S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinoma

  2021cites this paper
• Diabetes and Pancreatic Cancer—A Dangerous Liaison Relying on Carbonyl Stress

  2021cites this paper
• Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors

  2021cites this paper
• Intravenous Delivery of Lung‐Targeted Nanofibers for Pulmonary Hypertension in Mice

  2021cites this paper
• Inhibition of the Receptor for Advanced Glycation End Products Enhances the Cytotoxic Effect of Gemcitabine in Murine Pancreatic Tumors

  2021cites this paper
• Role of Advanced Glycation End-Products and Other Ligands for AGE Receptors in Thyroid Cancer Progression

  2021cites this paper
• The Role of the C-Terminal Lysine of S100P in S100P-Induced Cell Migration and Metastasis

  2021cites this paper
• S100P as a marker for poor survival and advanced stage in gallbladder carcinoma.

  2021cites this paper
• RAGE Up-Regulation Differently Affects Cell Proliferation and Migration in Pancreatic Cancer Cells

  2020cites this paper
• Quantitative imaging of the receptor for advanced glycation end-products in prostate cancer

  2020cites this paper
• The receptor for advanced glycation end-products enhances lung epithelial wound repair: An in vitro study.

  2020cites this paper
• A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis

  2020cites this paper
• Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression

  2020cites this paper
• Effects of RAGE inhibition on the progression of the disease in hSOD1G93A ALS mice

  2020cites this paper
• RAGE and its ligands: from pathogenesis to therapeutics

  2020cites this paper
• Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetes

  2020cites this paper
• Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit

  2020cites this paper
• AGE-RAGE synergy influences programmed cell death signaling to promote cancer

  2020cites this paper
• Receptor for Advanced Glycation End Products Antagonism Blunts Kidney Damage in Transgenic Townes Sickle Mice

  2019cites this paper
• Inhibition of RAGE Axis Signaling: A Pharmacological Challenge.

  2019cites this paper
• S100 proteins: Diagnostic and prognostic biomarkers in laboratory medicine.

  2019cites this paper
• Differential characteristics of HMGB2 versus HMGB1 and their perspectives in ovary and prostate cancer.

  2019cites this paper
• Coalescence of RAGE in Lipid Rafts in Response to Cytolethal Distending Toxin-Induced Inflammation

  2019cites this paper
• Ca2+-Binding Proteins of the EF-Hand Superfamily: Diagnostic and Prognostic Biomarkers and Novel Therapeutic Targets.

  2019cites this paper
• Cell non-autonomous functions of S100a4 drive fibrotic tendon healing

  2019cites this paper
• HGMB1 and RAGE as Essential Components of Ti Osseointegration Process in Mice

  2019cites this paper
• Effects of RNA binding protein QKI on pancreatic cancer ductal epithelial cells and surrounding activation fibroblasts

  2019cites this paper
• S100P regulates the collective invasion of pancreatic cancer cells into the lymphatic endothelial monolayer.

  2019cites this paper
• Characterization of the RAGE-binding protein, Strongyloides venestatin, produced by the silkworm-baculovirus expression system.

  2019cites this paper
• Prognostic value of pre-treatment peripheral blood markers in pancreatic ductal adenocarcinoma and their association with S100A4 expression in tumor tissue

  2019cites this paper
• Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis

  2019cites this paper
• The advanced glycation endproduct Nε-carboxymethyllysine promotes progression of pancreatic cancer: implications for diabetes-associated risk and its prevention Running title: AGEs as diabetes-related risk factor for pancreatic cancer

  2019influential citation
• Discovery of Novel and Clinically Relevant Markers in Formalin-Fixed Paraffin-Embedded Esophageal Cancer Specimen

  2018cites this paper
• Nicotine induces apoptosis in human osteoblasts via a novel mechanism driven by H2O2 and entailing Glyoxalase 1‐dependent MG‐H1 accumulation leading to TG2‐mediated NF‐kB desensitization: Implication for smokers‐related osteoporosis

  2018cites this paper
• Inhibition of the Receptor for Advanced Glycation End-Products in Acute Respiratory Distress Syndrome: A Randomised Laboratory Trial in Piglets

  2018cites this paper
• The advanced glycation end‐product Nϵ‐carboxymethyllysine promotes progression of pancreatic cancer: implications for diabetes‐associated risk and its prevention

  2018influential citation
• Interplay between Trx‐1 and S100P promotes colorectal cancer cell epithelial–mesenchymal transition by up‐regulating S100A4 through AKT activation

  2018cites this paper
• High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target.

  2018cites this paper
• The RAGE signaling pathway is involved in intestinal inflammation and represents a promising therapeutic target for Inflammatory Bowel Diseases

  2018cites this paper
• Sporadic Pancreatic Cancer: Glucose Homeostasis and Pancreatogenic Type 3 Diabetes

  2018cites this paper
• Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke

  2018cites this paper
• RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer—a Review

  2018cites this paper
• MRTF-A mediated FN and ICAM-1 expression in AGEs-induced rat glomerular mesangial cells via activating STAT5.

  2018influential citation
• Role of DAMPS on the modulation of macrophage response after classical biomaterial (Ti) implantation and its impact on the subsequent repair and osseointegration processes

  2018cites this paper
• S100A12 in renal and cardiovascular diseases

  2017cites this paper
• Sphingosine kinase 1 mediates AGEs-induced fibronectin upregulation in diabetic nephropathy

  2017influential citation
• Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis

  2017cites this paper
• Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective

  2017cites this paper
• Nitration and Glycation Turn Mature NGF into a Toxic Factor for Motor Neurons: A Role for p75NTR and RAGE Signaling in ALS

  2017cites this paper